W

West Coast Retina Medical Group Inc. | West Coast Retina Medical Group - San Francisco

Research site

(Unclaimed)

Location

1445 Bush Street, San Francisco, California, United States of America

Site insights

Top conditions

Top treatments

Ranibizumab

EYP-1901

Faricimab

Triamcinolone Acetonide

ranibizumab

zeaxanthin

Aflibercept

EPA

Lampalizumab

GB-102

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 18 total trials

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Active, not recruiting

Wet Age Related Macular Degeneration

wAMD

Drug: Aflibercept (2.0 mg)

Drug: EYP-1901

Extension Study for the Port Delivery System With Ranibizumab (Portal)

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with ne...

Enrolling

Neovascular Age-Related Macular Degeneration

Drug: PDS Implant with Ranibizumab 100 mg/mL

Study of Zifibancimig in Participants With Neovascular Age-Related Macular Degeneration (BURGUNDY)

This is a first in-human study to investigate the safety, tolerability and efficacy of zifibancimig administered through intravitreal (IVT) injection...

Enrolling

Macular Degeneration

Drug: Ranibizumab

Drug: Zifibancimig